home / stock / allr / allr news

ALLR News and Press, Allarity Therapeutics Inc. From 07/10/23

Stock Information
Company Name: Allarity Therapeutics Inc.
Stock Symbol: ALLR
Market: NASDAQ
Website: allarity.com
Menu
ALLR ALLR Quote ALLR Short ALLR News ALLR Articles ALLR Message Board
Get ALLR Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLR - NVAX and OM among healthcare movers

2023-07-10 10:03:22 ET Gainers: NanoString Technologies ( NSTG ) +23% . NeuroOne Medical Technologies Corporation ( NMTC ) +21% . Novavax ( NVAX ) +18% . Sientra ( SIEN ) +15% . Losers: Outset Medical ( OM ) -12% . PainRe...
ALLR - Castle Biosciences, CareDx top healthcare gainers; PainReform, Aslan among losers

2023-07-07 10:07:00 ET Gainers: Castle Biosciences ( CSTL ) +43% . CareDx ( CDNA ) +20% . COMPASS Pathways ( CMPS ) +9% . TG Therapeutics ( TGTX ) +9% . KalVista Pharmaceuticals ( KALV ) +8% . Losers: PainReform ( P...

ALLR - BNED, UGRO and NLSP among mid-day movers

2023-07-06 13:08:25 ET Gainers: EdtechX Holdings Acquisition ( EDTX ) +40% . Mullen Automotive ( MULN ) +35% . Genius Sports Limited ( GENI ) +21% . Incannex Healthcare Limited ( IXHL ) +19% . Sweetgreen ( SG ) +18% . urban-g...

ALLR - Allarity Therapeutics falls after pricing public offering to raise $11M

2023-07-06 06:22:56 ET Allarity Therapeutics ( NASDAQ: ALLR ) prices public offering of 2.44M common shares and common warrants to purchase up to 2.44M common shares at an effective combined price of $4.50 per share and common warrant for aggregate gross proceeds of ~$11M. The...
ALLR - Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering

BOSTON, MA (July 6, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized canc...

ALLR - Allarity Therapeutics Inc. (NASDAQ: ALLR) Leading the Way in Wednesday Trading Based on Percentage Gain

Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today's top gainers. The company's shares are currently up 56.51% on the day to $9.86. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnosti...

ALLR - Initial Data from Allarity's Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients

Boston , MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnostics for p...
ALLR - Allarity Therapeutics clarifies on effective reverse stock split date

2023-06-28 01:55:32 ET Clinical-stage pharmaceutical company, Allarity Therapeutics ( NASDAQ: ALLR ) clarifies the effective date of its contemplated reverse stock split. The company is clarifying that the reverse stock split will not be effected on June 27, 2023,...

ALLR - Allarity Therapeutics Announces Clarification of Effective Date for Reverse Stock Split

Press Release BOSTON, MA (June 27, 2023) – Allarity Therapeutics, Inc. (NASDAQ: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnos...

ALLR - Allarity Therapeutics Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to Friday, June 23 , 2023 at 1 :00 p .m. Eastern Time Press release BOSTON, MA (June 20, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage ...
Previous 10 Next 10